ES8201129A1 - Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii - Google Patents

Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii

Info

Publication number
ES8201129A1
ES8201129A1 ES498583A ES498583A ES8201129A1 ES 8201129 A1 ES8201129 A1 ES 8201129A1 ES 498583 A ES498583 A ES 498583A ES 498583 A ES498583 A ES 498583A ES 8201129 A1 ES8201129 A1 ES 8201129A1
Authority
ES
Spain
Prior art keywords
radical
group
nitrogen atom
protective group
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES498583A
Other languages
English (en)
Other versions
ES498583A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES8201129A1 publication Critical patent/ES8201129A1/es
Publication of ES498583A0 publication Critical patent/ES498583A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN OCTAPEPTIDO DE EFECTOS ANTAGONICOS DE LA ANGIOTENSINA-II, DE FORMULA GENERAL (I), DONDE X REPRESENTA EL GRUPO ACILO DE UN ACIDO N-METILAMINO; Y ES EL RESIDUO DE UNA CIDO -HIDEOXICARBOXILICO ALIFATICO; A ES HIDROGENO O UN GRUPO ALQUILO C1-5 Y SE SUS SALES DE ADICION ACIDAS O COMPLEJAS FARMACEUTICAMENTE ACEPTABLES. PARA PREPARAR UN COMPUESTO DE FORMULA (I), EN EL QUE A ES HIDROGENO, SE SEPARAN ESCALONADAMENTE, O EN UNA SOLA OPERACION, LOS GRUPOS PROTECTORES DE UN DERIVADO OCTAPEPTIDO PROTEGIDO, DE FORMULA GENERAL (II), DONDE B ES UN GRUPO SEPARABLE POR ACIDOLISIS O HIGROGENACION CATALITICA; C ES UN GRUPO DESTINADO A LA PROTECCION TEMPORAL DEL GRUPO GUANIDINO DE LA MITAD ARG; D ES UN GRUPO DESTINADO A LA PROTECCION TEMPORAL DEL GRUPO HIDROXILO AROMATICO DE LA MITAD TIR; E ES UN GRUPO DESTINADO A LA PROTECCION TEMPORAL DEL GRUPO IMIDAZOL DE LA MITAD HIS, Y F ES UN GRUPO DESTINADO A LA PROTECCION DEL GRUPO CARBOXILO TERMINAL. CUANDO A ES UN GRUPO ALQUILO C1-5 EN L COMPUESTO DE FORMULA (I), SE SEPARAN TAMBIEN ESCALONADAMENTE, O EN UNA SOLA OPERACION, LOS GRUPOS PROTECTORES DE UN OCTAPEPTIDO PROTEGIDO DE FORMULA GENERAL (III). X-ARG-VAL-TIR-IIE-HIS-PRO-Y-OA (I) B-X-ARG(C)-VAL-TIR(D)-IIE-HIS(E)-PRO-Y-OF (II) B-X-ARG(C)-VAL/TIR(D)-LLE-HIS(E)-PRO-Y-OA (III).
ES498583A 1980-01-18 1981-01-16 Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii Granted ES498583A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8080100A HU181008B (en) 1980-01-18 1980-01-18 Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position

Publications (2)

Publication Number Publication Date
ES8201129A1 true ES8201129A1 (es) 1981-12-01
ES498583A0 ES498583A0 (es) 1981-12-01

Family

ID=10947908

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498583A Granted ES498583A0 (es) 1980-01-18 1981-01-16 Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii

Country Status (19)

Country Link
US (1) US4330532A (es)
EP (1) EP0034260B1 (es)
JP (1) JPS56142251A (es)
AT (1) ATE4197T1 (es)
AU (1) AU541000B2 (es)
CA (1) CA1149377A (es)
CS (1) CS219939B2 (es)
DE (1) DE3160608D1 (es)
DK (1) DK149777C (es)
ES (1) ES498583A0 (es)
FI (1) FI73225C (es)
HU (1) HU181008B (es)
IL (1) IL61922A (es)
IN (1) IN153279B (es)
NO (1) NO151409C (es)
PH (1) PH17196A (es)
PL (1) PL130448B1 (es)
SU (1) SU993816A3 (es)
YU (1) YU42550B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182264A (en) * 1986-03-07 1993-01-26 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
DE19529604A1 (de) * 1995-08-11 1997-02-13 Bayer Ag Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company 腎不全を処置するための組成物及び方法
JP6824739B2 (ja) 2013-12-18 2021-02-03 ザ ジョージ ワシントン ユニヴァーシティ、ア コングレッショナル チャータード ノット−フォー−プロフィット コーポレーション 低血圧治療のための単独または併用使用されるアンギオテンシンii
WO2017120438A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947575A (en) * 1969-06-30 1976-03-30 E. R. Squibb & Sons, Inc. Peptides as argiotensin converting enzyme inhibitors
DE2323322A1 (de) * 1973-05-09 1974-11-28 Hoechst Ag Neue peptide mit blutdrucksenkender wirkung und verfahren zu ihrer herstellung
US3923770A (en) * 1974-05-10 1975-12-02 Francis Merlin Bumpus {8 Me{hd 2{b Gly{hu 1{b , Ile{hu 8{b {9 -Anziotensin II as an angiotensin antagonist
US3923769A (en) * 1974-05-10 1975-12-02 Francis Merlin Bumpus {8 N-Me-Ile{40 ,Ile{hu 8{b {9 -Angiotensin II as an angiotensin antagonist
US3915948A (en) * 1974-08-05 1975-10-28 Morton Norwich Products Inc Sarcosyl-L-arginyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-proline
DE2457463A1 (de) * 1974-12-05 1976-06-10 Hoechst Ag Neue peptide mit blutdrucksenkender wirkung und verfahren zu ihrer herstellung
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US3976770A (en) * 1975-02-10 1976-08-24 Francis Merlin Bumpus Sar'-(OMe)Thr8 Angiotensin II as an angiotensin II antagonist
HU177133B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
HU177134B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha-hydroxy-acid in position 1 with angiotensin ii antagonist activity

Also Published As

Publication number Publication date
EP0034260A1 (de) 1981-08-26
DK20481A (da) 1981-07-19
ATE4197T1 (de) 1983-08-15
DK149777C (da) 1987-04-21
YU42550B (en) 1988-10-31
PL130448B1 (en) 1984-08-31
AU6627681A (en) 1981-07-23
AU541000B2 (en) 1984-12-13
CA1149377A (en) 1983-07-05
YU9381A (en) 1983-09-30
IL61922A0 (en) 1981-02-27
US4330532A (en) 1982-05-18
NO151409C (no) 1985-04-10
PH17196A (en) 1984-06-19
DK149777B (da) 1986-09-29
NO151409B (no) 1984-12-27
IL61922A (en) 1984-01-31
SU993816A3 (ru) 1983-01-30
IN153279B (es) 1984-06-23
NO810149L (no) 1981-07-20
DE3160608D1 (en) 1983-08-25
PL229223A1 (es) 1982-03-01
FI73225C (fi) 1987-09-10
FI810123L (fi) 1981-07-19
JPS56142251A (en) 1981-11-06
ES498583A0 (es) 1981-12-01
FI73225B (fi) 1987-05-29
CS219939B2 (en) 1983-03-25
HU181008B (en) 1983-05-30
EP0034260B1 (de) 1983-07-20

Similar Documents

Publication Publication Date Title
AU578781B2 (en) Novel peptide derivatives having a nitrogenous polycyclic structure, process for the preparation thereof and pharmaceutical compositions containing them
IL61923A0 (en) Angiotensin-ii analogues containing an ester group in position 8,and process for the preparation thereof
KR860004081A (ko) 폴리펩티드의 제조방법
CA1188218A (en) PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS
ES8405363A1 (es) Procedimiento para la obtencion de un octapeptido ciclico.
PT76333A (en) Process for preparing dipeptide sweetener-metal complexes
ES8201129A1 (es) Procedimiento de preparacion de un octapeptido de efectos antagonicos de la angiotensina-ii
FI892185A (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
EP0384341A3 (en) New proline derivatives
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
HU896606D0 (en) Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
Anderson et al. [49] Preparation and use of glutathione monoesters
ES8303353A1 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
KR910000791A (ko) 뉴로키닌 a 길항제
GB984810A (en) Polypeptides
CA1331499C (en) Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments
GB992957A (en) New decapeptides and their manufacture
KR920019813A (ko) 치환2',3'-디데옥시-5- 트리플루오로메틸우리딘, 그의 제조 방법 및 의약으로서의 그의 용도
ES8705367A1 (es) Un procedimiento para preparar derivados de aminoacidos
Shin et al. Convenient Synthesis of Dehydrooligopeptides by the Solid Phase Method Using N-Carboxy α-Dehydroamino Acid Anhydride
ATE3205T1 (de) Psycho-pharmakologische peptide, verfahren zu ihrer herstellung und sie enthaltende therapeutische zusammensetzungen.
JPS57145846A (en) Preparation of tripeptide and its derivative
KR870007207A (ko) 소마토스타틴 유도체의 제조방법